CRA developed economic analyses to determine damages in a patent infringement case involving a pharmaceutical product used for the treatment of congestive heart failure and skinny labeling by a generic competitor. CRA provided an initial report on economic damages calculating lost profits and reasonable royalties as well as deposition and trial testimony.
CRA Sessions: AI in Practice | Copyright in the age of AI: Following the evidence
A historic $1.5 billion settlement by Anthropic delivered the first significant judicial ruling on the issue. The ruling is expected to influence how courts,...